Trial | NCT04205201  Report issue

Official Title

The Effectiveness of Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma

  • Phase

    Phase 2

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    80
Outpatient department of cmch, ceitc,cimch POAG patients enrolled for the study.
Study Started
Jun 25
2018
Primary Completion
Sep 24
2019
Study Completion
Oct 05
2019
Last Update
Dec 26
2019

Drug Drugs, Investigational [brimonidine (alphagan), latanoprost (xalatan)]

To see the safety and efficacy of topical latanoprost compared with topical brimonidine in the treatment of the primary open angle

  • Other names: Brimonidine

Group A Experimental

Latanoprost

Group B Other

Brimonidine

Criteria 

Inclusion Criteria:

IOP 22_34mmof Hg,newly diagnosed case, bilateral POAG patients Patients.

Exclusion Criteria:

pregnant and lactating women, infection, any eye surgery.
No Results Posted